This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Hill-Rom Holdings Management Presents At Credit Suisse Group Healthcare Conference - Conference Call Transcript

In the businesses in which we compete, we hold a number one or number two position in each of those categories, I won't go through each of these but you can see it on the left hand side that, about half of our categories, we hold the number one position and a little more than half categories, we hold the number two position. So, we hold a very competitive place in the marketplace. And you know we attribute that to the competitive differentiation in the value proposition that we bring across that Care Continuum.

If you look at fiscal 2011, and you breakdown our revenue, first by reporting segment, we organize our business into three segments, North America Acute Care which is focused on the hospital. North American, Post-Acute, where we have three businesses, our Respiratory Care business and then also extended care and home care and the Post-Acute Setting and then our international business, which has a combination of all of those, outside of North America.

You can see that little over 60% comes from North America Acute, of that about a quarter from international and 13% in our Post-Acute business. If you break that down by business model, as I mentioned earlier, we have rental revenue and also revenue from sales, a combination of capital software and services. You can see that 70% of it is from the capital software and services and about a third of it from rental.

And then, finally if you break it down by geography, you can see the three quarters of revenue is generated in North America, 17% Europe and a little less than 10% in the rest of the world.

We recognized that there is, multiple challenges in today’s environment. And we think we have responses from many of those. I’m not going to walk through every one of these points, but certainly, you know, one of our challenges today is to provide more care with fewer resources. And we believe that our product offerings and our services are differentiated in terms of the outcomes that they can provide. We do believe that we offer a return on investment. We believe that we are an investment versus the cost and that we have clinical data to support that that we can prove outcomes and reduce operating expenses.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs